Parafollicular cells of the thyroid gland produce calcitonin (CT) which is responsible for regulating the calcium metabolism. Apart from its physiological functions, recent studies have shown that CT plays a major role in carcinogenesis. [1] [2] [3] [4] The role of CT in carcinogenesis varies significantly according to the type of cancer. 3 The present text summarizes the varying effects of CT in cancer. Calcitonin and calcitonin receptors (CTRs) play an important role in regulating tumor development, cell proliferation, adhesion, migration, metastasis, cell survival, and apoptosis. The CTRs belong to G mitogen-activated protein-coupled seven transmembrane domain receptor (GPCR) superfamily. The CTRs control the activity of protein kinases (MAPK) superfamily which gets activated by exposure to mutagens. These include extracellular signal-regulated kinases 1 (Erk1) and 2 (Erk2) (or p44 MAPK and p42 MAPK), c-Jun NH (2)-terminal kinases, p38 MAPK, and Erk5 (or BMK). Among these kinases, Erk1 and Erk2 are the ones which regulate cellular responses like cell proliferation. The Erks are activated by a phosphorylation cascade brought about by initiation of ras, a proto-oncogene exposed to a mutagen. The GPCR may signal ras via various signaling pathways that may vary in different cell types and lines.
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In addition to regulating cellular proliferation, Erk1/2 activation leads to increase in urokinase plasminogen activator (uPA) expression which leads to disruption of basement membrane and destruction of the extracellular matrix.
2 Being a protease, uPA can convert plasminogen to plasmin, thereby regulating cell migration through the modulation of cell membrane adherence with the surrounding extracellular matrix. It also plays a role in normal tissue repair, cancer invasiveness, and metastasis. 2 A correlation between an increased expression of uPA and its receptors with tumor invasiveness and tumor stage has been reported. 2 T47D showed inhibition of cell proliferation. The CT treatment caused a downregulation of uPA and urokinase plasminogen activator receptor in MDA-MB-231 cells, thus inhibiting its invasiveness in vitro. The authors also observed that the treatment of MDA-MB-231 xenograft cells with CT resulted in a reduced uPA mRNA expression in vivo. They suggested that inhibition of tumor invasion was concentration-dependent, seen in only those cell cultures treated with CT for a longer duration (nearly a day). 3 It is believed that CT alters the phenotype of MDA-MB-231 cells, thereby decreasing its invasive potential. 3 Advanced cases with tumor invasion through lymphatics and metastasis to lymph nodes showed a reduced CTR mRNA expression. 2 Segawa et al. 4 reported that in DU145
prostate cancer cells, CT inhibited the phosphorylation of protein kinase. It is said that the MAP kinases cascade inhibition mediated by the PKA pathway was inhibited by the CT treatment and activation of the CTR. Earlyresponse genes, c-fos, and c-jun may be controlled by CT which is mediated by MAPK cascade. 4 G proteins compete for the CTR binding sites and this ability affects signal transduction by CT, depending on the different types of cells. The growth of breast cancer cell line T47D is halted by CT. In addition, CT inhibits the epidermal growth factor or insulin which stimulates the tumor growth in these cell lines. Tissue inhibitors of metalloproteases and parathyroid hormone-related protein which regulate the skeletal metastasis are also regulated by CT in breast cancer. 3 Thus, to conclude, in CTR-expressing cancers, CT could be a potential therapeutic option to control tumor progression.
